December 2 - 4, 2020
Hyatt Regency Cambridge,
Connect with Key Stakeholders and Propel Curative Progress, Orphan Product Success and Patient Advocacy
CBI/EBD Group’s Rare Disease Summit convenes industry, patient groups, investors and policy makers to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs.
Rare Disease Article Pack
We have made available a series of articles highlighting various topics in rare disease research and regulation, and some companies involved in innovative drug development.
Bruce L. Levine is a man you can thank for your future cell therapy
Catch up on Bruce L. Levine's research and outlook on cell and gene therapies, and the importance of partnerships in progressing the field.
2019 KEYNOTE TOPICS INCLUDED:
Patient and Caregiver Perspectives –
Explore New Developments in Cures, Community, Collaboration and the Care Continuum for Patients and Caregivers
Science Luminaries –
Advancements in Gene Therapy that Are Tearing Down Barriers to Discovery in Rare Disease
Regulatory and Policy Update Address –
Legislative Updates and New Initiatives within the FDA’s Orphan Drug Program
Focus on Funding –
The Impact of Disruptive Investors, Drivers of Value and Funding Models for Success
Technology Spotlight –
Artificial Intelligence (AI) and Advanced Data Analytics — Reshaping Complex Diagnostics and Decision-Making in Rare Disease Drug Development
Download the 2020 Preview
See all the latest updates for CBI/EBD Group’s 2020 Rare Disease Summit.
Connect with Key Decision-Makers at the Rare Disease Summit
Whether you’re looking to generate quality leads, showcase thought leaders, or reinforce your brand, collaborate with us to identify custom sponsorship opportunities to help you reach your business objectives.
For more information about opportunities to reach a qualified audience, contact LifeSciencePartners@informaconnectls.com.